Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Dang

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Cancer Research|January 26, 2000
c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expressionL F Barr, S E Campbell, G B Diette, et al.
Annals of Emergency Medicine|September 1, 1984
The use of gated radionuclide angiography in the diagnosis of cardiac contusionJ E Fenner, R Knopp, B Lee, et al.
Oncogene|October 11, 2001
c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuliF Kuttler, P Amé, H Clark, et al.
Oncogene|December 1, 1990
A potential transcriptional activation element in the p53 proteinR W O'Rourke, C W Miller, G J Kato, et al.
Biochemical and Biophysical Research Communications|August 26, 1998
Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptorK I Lin, N Chattopadhyay, M Bai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1997
c-Myc transactivation of LDH-A: implications for tumor metabolism and growthH Shim, C Dolde, B C Lewis, et al.
The Journal of Biological Chemistry|May 24, 2000
Deregulation of glucose transporter 1 and glycolytic gene expression by c-MycR C Osthus, H Shim, S Kim, et al.
Molecular and Cellular Biology|August 1, 1995
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domainA T Hoang, B Lutterbach, B C Lewis, et al.
Annals of Internal Medicine|December 29, 1998
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune diseaseR A Brodsky, M Petri, B D Smith, et al.
Cancer Research|November 21, 2000
Identification of c-myc responsive genes using rat cDNA microarrayQ M Guo, R L Malek, S Kim, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Cancer Research|January 26, 2000
c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expressionL F Barr, S E Campbell, G B Diette, et al.
Annals of Emergency Medicine|September 1, 1984
The use of gated radionuclide angiography in the diagnosis of cardiac contusionJ E Fenner, R Knopp, B Lee, et al.
Oncogene|October 11, 2001
c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuliF Kuttler, P Amé, H Clark, et al.
Oncogene|December 1, 1990
A potential transcriptional activation element in the p53 proteinR W O'Rourke, C W Miller, G J Kato, et al.
Biochemical and Biophysical Research Communications|August 26, 1998
Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptorK I Lin, N Chattopadhyay, M Bai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1997
c-Myc transactivation of LDH-A: implications for tumor metabolism and growthH Shim, C Dolde, B C Lewis, et al.
The Journal of Biological Chemistry|May 24, 2000
Deregulation of glucose transporter 1 and glycolytic gene expression by c-MycR C Osthus, H Shim, S Kim, et al.
Molecular and Cellular Biology|August 1, 1995
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domainA T Hoang, B Lutterbach, B C Lewis, et al.
Annals of Internal Medicine|December 29, 1998
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune diseaseR A Brodsky, M Petri, B D Smith, et al.
Cancer Research|November 21, 2000
Identification of c-myc responsive genes using rat cDNA microarrayQ M Guo, R L Malek, S Kim, et al.
Pageof 13